We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
QIAGEN Launches Assays for miRNA Research, Gene Silencing and DNA-Methylation Analysis
Product News

QIAGEN Launches Assays for miRNA Research, Gene Silencing and DNA-Methylation Analysis

QIAGEN Launches Assays for miRNA Research, Gene Silencing and DNA-Methylation Analysis
Product News

QIAGEN Launches Assays for miRNA Research, Gene Silencing and DNA-Methylation Analysis


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "QIAGEN Launches Assays for miRNA Research, Gene Silencing and DNA-Methylation Analysis"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

From now on researchers can find ready-to-use QIAGEN assays and reagents that allow the customization of experiments based on the gene of interest. On GeneGlobe®, QIAGEN’s web portal, customers can explore and order gene and pathway specific products for a range of applications, the Company has announced.

For miRNA research, the miScript Target Protector is available for researchers doing functional analysis of miRNAs. The new FlexiTube siRNA Premix allows convenient one-step gene silencing in low-throughput applications for analysis of gene function.

For DNA-metyhylation analysis, the PyroMark™ CpG and Custom Assays are available using Pyrosequencing technology. In addition, the PyroMark™ OneStep RT-PCR Kit enables the reverse transcription and subsequent amplification of RNA samples in the same tube.

Altogether, there are more than 400 pathways available for a wide variety of organisms. “GeneGlobe combines state-of-the-art algorithms and access to the most updated information from scientific databases so scientists can build experimental success,” says Dr. Janina Lehmann, QIAGEN’s Director Global Business Gene Expression & Function. “This allows us to offer the broadest portfolio in sample and assay technologies for gene and pathway analysis in the market and provide assays that are validated and ready-to-use.”
Advertisement